Concepedia

Katja S. Kroker

KS

Statistics

Publications

11

Citations

473

H-Index

10

Active since

2010

Affiliations

Boehringer Ingelheim (Germany)(Current)

Universität Ulm

Katja S. Kroker is an author at Boehringer Ingelheim (Germany) specializing in neuroscience, life sciences, and neuropharmacology.

Publications per year

2010–2018

11

Publications

11

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Stefan Just, Bertrand L. Chenard, Angelo Ceci et al. · PLoS ONE · 2018 · 139 citations · Full text

, , +17

PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition

Katja S. Kroker, Chantal Mathis, Anelise Marti et al. · Neurobiology of Aging · 2014 · 64 citations

, , +16

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP

Katja S. Kroker, Georg Rast, Riccardo Giovannini et al. · Neuropharmacology · 2012 · 59 citations

, , +14

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

Raphael Hesse, Ludwig Lausser, Pauline Gummert et al. · Alzheimer s Research & Therapy · 2017 · 45 citations · Full text

, , +17

Inhibition of PDE2A, but not PDE9A, modulates presynaptic short‐term plasticity measured by paired‐pulse facilitation in the CA1 region of the hippocampus

Diego Fernández‐Fernández, Holger Rosenbrock, Katja S. Kroker · Synapse · 2015 · 36 citations

, , +16

1–5 of 11